CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement

Efficacy and toxicity of chimeric antigen receptor T (CAR-T) cell therapy in relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) involvement remain understudied. Here we analyzed the outcomes of CAR-T cell therapy in r/r DLBCL patients with CNS involveme...

Descripción completa

Detalles Bibliográficos
Autores principales: Shumilov, Evgenii, Boyadzhiev, Hristo, Mazzeo, Paolo, Akhoundova, Dilara, Daskalakis, Michael, Novak, Urban, Lenz, Georg, Bacher, Ulrike, Pabst, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691788/
https://www.ncbi.nlm.nih.gov/pubmed/38044958
http://dx.doi.org/10.1097/HS9.0000000000000984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691788/
https://www.ncbi.nlm.nih.gov/pubmed/38044958
http://dx.doi.org/10.1097/HS9.0000000000000984

Ejemplares similares